ReNerve Limited (ASX:RNV)
Australia · Delayed Price · Currency is AUD 0.0900
0.00 (0.00%)
Oct 28, 2026, 3:43 PM AEDT
ReNerve Market Cap
ReNerve has a market cap or net worth of 15.51 million as of October 29, 2026. It is the 40,945th most valuable company in the world and the 1,153rd biggest in Australia. Its market cap has decreased by 6.28% in one year.
Market Cap
15.51M
Enterprise Value
14.22M
Revenue
510.36K
Global Rank
Country Rank
#1,153 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since November 26, 2024, ReNerve's market cap has decreased from 26.95M to 15.51M, a decrease of -42.46%. That is a compound annual growth rate of -25.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 15.51M | -6.28% |
| Dec 31, 2025 | 16.55M | -33.34% |
| Dec 31, 2024 | 24.82M | -7.89% |
| Nov 26, 2024 | 26.95M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NeuroScientific Biopharmaceuticals | 20.27M |
| Proteomics International Laboratories | 19.84M |
| Algorae Pharmaceuticals | 18.25M |
| Imugene | 17.14M |
| Patrys | 15.72M |
| Noxopharm | 15.05M |
| Ceryvyn Therapeutics | 15.05M |
| EZZ Life Science Holdings | 14.36M |